Another important aspect to consider is the impact on overall benefit-risk assessment ... on the other hand. European Medicines Agency. Guideline on Immunogenicity Assessment of Biotechnology ...

Access to medicines is “one of the most challenging policy areas in every country in the European region ... is leading to additional health benefits and health gains, but they are ...